U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.83 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.11 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.46
    +2.70 (+2.55%)
     
  • Gold

    1,812.90
    +5.60 (+0.31%)
     
  • Silver

    19.85
    -0.50 (-2.44%)
     
  • EUR/USD

    1.0426
    -0.0057 (-0.54%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • GBP/USD

    1.2103
    -0.0072 (-0.59%)
     
  • USD/JPY

    135.1750
    -0.5530 (-0.41%)
     
  • BTC-USD

    19,087.23
    -180.28 (-0.94%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    25,935.62
    -457.42 (-1.73%)
     

At 3.5% CAGR, Global Epilepsy Therapeutics Market Size & Share To Surpass USD 18.1 Billion by 2028 | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research

·10 min read

NEW YORK, June 13, 2022 /PRNewswire/ -- As per Zion Market Research study, The global epilepsy therapeutics market was valued at over $13 billion in 2021 and is likely to surpass $18.1 billion by the end of 2028. The market is expected to expand at a considerable CAGR of 3.5% during the forecast period.

Zion Market Research Logo
Zion Market Research Logo

Key Industry Insights & Finding of the Epilepsy Therapeutics Market Reports:

  • As per the analysis shared by our research analyst, the Epilepsy Therapeutics Market is expected to grow annually at a CAGR of around 3.5 % (2022-2028).

  • Through the primary research, it was established that the Epilepsy Therapeutics Market was valued approximately USD 13 Billion in 2021 and is projected to reach to roughly USD 18.1 Billion by 2028.

  • This is majorly due to higher investments in R&D, increasing awareness and availability of advanced Epilepsy Therapeutics drugs in North America region.

  • Asia Pacific is witnessing a significant growth in the global Epilepsy Therapeutics market over the upcoming years. Due government initiatives in the field, Increased awareness and technological advancement in field is fueling the growth of global Epilepsy Therapeutics market.

Zion Market Research published the latest report titled as  "Epilepsy Therapeutics Market By Drugs (First Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Generation Anti-Epileptics), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others), By Location (Rural And Urban), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data And Forecasts 2022 – 2028." into their research database.

Epilepsy Therapeutics Market: Overview

Epilepsy Therapeutics refers to chronic neurological disorder which causes constant and unfounded seizures. An individual suffering from Epilepsy Therapeutics tends to have seizures with no explanation. In Epilepsy Therapeutics, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. The increase in the number of accidents and brain injuries and the high rate of post-traumatic Epilepsy Therapeutics (PTE) and post-traumatic seizure (PTS) occurrence in patients with brain injuries are the major factors driving the Epilepsy Therapeutics treatment market.

Furthermore, innovation of new treatment products with better efficiency is expected to further drive this market. Rising number of mergers and acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest trends that have been observed in the global Epilepsy Therapeutics market. Besides development of new drugs and treatment options, approval and launch of new products extend profitable opportunities to the Epilepsy Therapeutics treatment market players in the forecast period.

In Addition, development of highly efficacious products, having less side-effects, and better outcomes are likely to propel the Epilepsy Therapeutics market Neurological disorders have become a matter of concern for medical researchers who are looking at optimizing medical treatments. Furthermore, the adoption of anti-epileptics due to increasing seizures and Epilepsy Therapeutics cases, and a rise in research and development is driving the growth of Epilepsy Therapeutics market. .However, factors such as lack of awareness about the condition some developing regions and reluctance to adopt Epilepsy Therapeutics medications in some regions are restraining the growth of the Epilepsy Therapeutics market over the upcoming years.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/epilepsy-therapeutics-market

Our Free Sample Report Includes:

  • 2022 Updated Report Introduction, Overview, and In-depth industry analysis

  • COVID-19 Pandemic Outbreak Impact Analysis Included

  • 172 + Pages Research Report (Inclusion of Updated Research)

  • Provide Chapter-wise guidance on Request

  • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends

  • Includes Updated List of tables & figures

  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis

  • Zion Market Research methodology

Industry Dynamics:

Epilepsy Therapeutics Market: Growth Drivers

  • Active Government Support and Investments to Expedite Market Growth.

Governmental initiatives to improve the healthcare sectors and higher investments in R&D is anticipated to expand at a notable growth of Epilepsy Therapeutics market during the forecast period. Rise in the number of approvals by government bodies is providing beneficial for the patients in controlling the seizures. This is projected to fuel the adoption of anticonvulsant and boost the market growth over the upcoming years.

Epilepsy Therapeutics Market: Restraints

  • Epilepsy Medicine shortage to hamper the market growth.

One of the major factors restraining the growth of Epilepsy Therapeutics market during the forecast period is steep rise in medicine shortage. Patients are stockpiling these medicines as there is a shortage of drugs in pharmacies which has raised an alarm in investigating the medicine supply chain globally. This is ultimately affecting the global Epilepsy Therapeutics market as the market becomes less desirable for Epilepsy Therapeutics medications.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/epilepsy-therapeutics-market

Global Epilepsy Therapeutics Market: Segmentation

  • The global Epilepsy Therapeutics market is segregated based on Product, distribution channel, end-user, and region.

Based on distributional channel, the global Epilepsy Therapeutics market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is projected to dominate the global market. growing number of hospitals, along with adequate reimbursement policies provided by these settings, are some of the major factors responsible for higher growth of hospital pharmacy over the upcoming years. This is eventually responsible for the adoption of antiepileptic drugs by the hospital pharmacies globally.

Based on product market has been classified into first generation Epilepsy Therapeutic second-generation Epilepsy Therapeutics and third generation Epilepsy Therapeutics. The second-generation epilepsy therapeutics segment is expected to hold a significant share of the global epilepsy therapeutics. This is due to increased penetration in the market and better effectiveness as compared to first generation Epilepsy Therapeutics.

Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/epilepsy-therapeutics-market

List of Key Players of Epilepsy Therapeutics Market:

  • BIAL - PORTELA & CA SA

  • GlaxoSmithKline Plc

  • Johnson & Johnson Services Inc.

  • Novartis AG

  • Pfizer Inc.

  • SanofiSA

  • Sunovion Pharmaceuticals Inc.

  • UCB SA

  • Zogenix Inc.

Key questions answered in this report:

  • What are the growth rate forecast and market size for Epilepsy Therapeutics Market?

  • What are the key driving factors propelling the Epilepsy Therapeutics Market forward?

  • What are the most important companies in the Epilepsy Therapeutics Market Industry?

  • What segments does the Epilepsy Therapeutics Market cover?

  • How can I receive a free copy of the Epilepsy Therapeutics Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 13 Billion

Revenue forecast in 2028

USD 18.1 Billion

Growth Rate

CAGR of almost 3.5 % 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

BIAL - PORTELA & CA SA, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., SanofiSA, Sunovion Pharmaceuticals Inc., UCB SA and Zogenix Inc.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/91

Free Brochure: https://www.zionmarketresearch.com/requestbrochure/epilepsy-therapeutics-market

Recent Developments:

  • In January 2020, Eisai Co. Announced the launch of FYCOMPA in China  for the treatment of partial-onset seizures in patients aged 12 years and older.

Regional Dominance:

  • Increasing awareness and availability.

North America dominates the global market for Epilepsy Therapeutics during the forecast period. This is majorly due to higher investments in R&D, increasing awareness and availability of advanced Epilepsy Therapeutics drugs in this region. Moreover, improved healthcare facilities are driving the market for Epilepsy Therapeutics in North America during the forecast period.

Asia Pacific is witnessing a significant growth in the global Epilepsy Therapeutics market over the upcoming years. Due government initiatives in the field, Increased awareness and technological advancement in field is fueling the growth of global Epilepsy Therapeutics market.

Global Epilepsy Therapeutics Market is segmented as follows:

Epilepsy Therapeutics Market: By Types Covered Outlook (2022-2028)

  • Anti-Epileptic Drugs

  • Brain Surgery

  • Dietary Supplements

  • Ketogenic Diet

  • Surgical Therapies

Epilepsy Therapeutics Market: By End Users Covered Outlook (2022-2028)

  • Ambulatory Surgical Centers

  • Hospitals& Clinics

  • Home Care Settings

  • Neurology Centers

Epilepsy Therapeutics Market: By Products Covered Outlook (2022-2028)

  • First Generation Epilepsy Therapeutics

  • Second Generation Epilepsy Therapeutics

  • Third Generation Epilepsy Therapeutics

Epilepsy Therapeutics Market: By Distribution Channels Covered Outlook (2022-2028)

  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy-User

Epilepsy Therapeutics Market: By Region Outlook (2022-2028)

North America

  • The U.S.

  • Canada

Europe

  • France

  • The UK

  • Spain

  • Germany

  • Italy

  • Rest of Europe

Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Southeast Asia

  • Rest of Asia Pacific

Latin America

  • Brazil

  • Mexico

  • Rest of Latin America

Middle East & Africa

  • GCC

  • South Africa

  • Rest of Middle East & Africa

Press Release For Epilepsy Therapeutics Market: https://www.zionmarketresearch.com/news/global-epilepsy-therapeutics-market

Browse Other Related Research Reports from Zion Market Research

  • Cannabis Cultivation Market - Global Industry Analysis: The global Cannabis Cultivation Market accrued earnings worth approximately 147.3 (USD Billion) in 2020 and is predicted to gain revenue of about 359.6 (USD Billion) by 2028, is set to record a CAGR of nearly 14.5% over the period from 2021 to 2028.

  • Pharmaceutical Sterility Testing Market - Global Industry Analysis: The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028.

  • Respiratory Disorders Treatment Market - Global Industry Analysis: The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.

Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/at-3-5-cagr-global-epilepsy-therapeutics-market-size--share-to-surpass-usd-18-1-billion-by-2028--industry-trends-value-analysis--forecast-report-by-zion-market-research-301566491.html

SOURCE Zion Market Research